Newsroom

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content.

by Neoteryx, on January 11,2022

January 2022 – As announced by Trajan Group Holdings Limited (ASX: TRJ) in early January from their headquarters in Australia, the company has acquired microsampling leader Neoteryx LLC. As reported …

Read Story

by Neoteryx, on December 1,2021

December 2021 — US-based medical device company Neoteryx announces its user-friendly at-home specimen collection kit for children in support of labs and research customers that conduct pediatric studies, clinical trials …

Read Story

by Neoteryx, on November 16,2021

November 2021 — The Mitra® microsampling device from US-based Neoteryx has been registered in Brazil as a Class 1 in vitro diagnostic (IVD) medical device by ANVISA, the Agência Nacional …

Read Story

by Neoteryx, on October 13,2021

Philadelphia, PA, October 2021 — The Science History Institute (the Institute) has announced Fasha Mahjoor as the recipient of the 21st annual Pittcon Heritage Award. Mahjoor is the founder and …

Read Story

by Neoteryx, on October 4,2021

ZA Approval of Mitra® Devices for Remote Specimen Collection at Home Gives Citizens Living in Rural Areas Greater Access to Critical Lab Services Los Angeles, USA & South Africa — …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news